EP2724728

ADMUNE THERAPEUTICS LLC
Application Number
EP13195499A
Filing Date
Jun 27, 2008
Status
Revoked
Mar 18, 2022
Grant Date
Oct 17, 2018
External Links
Slate, Register

Biblio Summary

The patent EP2724728B1 was granted on Oct 17, 2018 by Admune Therapeutics Llc The patent is currently Revoked.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HGF LIMITEDJul 16, 2019ADMISSIBLE

The table below shows the patents of Admune Therapeutics Llc that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2911684Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha ComplexesJun 19, 20191

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.